A strategic step forward for biomonitoring in constrained environments

TRAAK has announced the acquisition of Chronolife, a French biotech company renowned for its connected medical fabrics and advanced multiparametric digital health technologies. The aim of this strategic alliance is to integrate a medically certified physiological monitoring solution into TRAAK’s sovereign geolocation technology suite

From home healthcare to field-grade performance

Originally developed for remote patient monitoring, Chronolife’s technology enables continuous measurement of vital signals such as electrocardiogram (ECG), respiration, temperature, pysical activity and pulmonary impedance. Integrated into a robust, washable and discreet connected T-shirt – certified as a class IIa CE medical device – these sensors offer a reliable and proven solution.

From now on, this technology will be adapted for high-demand operational contexts: military operations, emergency response, industrial safety, and protection of lone workers. In these scenarios, every real-time physiological signal can help save lives and secure missions.

A fully Integrated and sovereign tactical tracking chain

By combining geolocation in all environments (indoor, outdoor, underground, GPS denied) with real-time multiparametric biomonitoring, TRAAK becomes the first provider to offer a fully integrated tactical tracking solution chain — from geolocation to physiological monitoring.

This acquisition significantly enhances our ability to support armed forces, emergency services, and industrial operators facing extreme conditions. It marks a key milestone in deploying sovereign, secure, and interoperable technologies designed to meet the evolving demands of high-intensity conflicts and critical operations.

Read the full press release to learn more